Cassava Sciences (SAVA) News Today → Log Into Marc's $5,000 System Today (From Chaikin Analytics) (Ad) Free SAVA Stock Alerts $21.27 -0.45 (-2.07%) (As of 02:33 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 19, 2024 | americanbankingnews.comHC Wainwright Raises Cassava Sciences (NASDAQ:SAVA) Price Target to $131.00May 17, 2024 | benzinga.comPeering Into Cassava Sciences's Recent Short InterestMay 17, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Given New $131.00 Price Target at HC WainwrightHC Wainwright raised their target price on Cassava Sciences from $124.00 to $131.00 and gave the stock a "buy" rating in a research report on Friday.May 16, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Shares Down 6% Cassava Sciences (NASDAQ:SAVA) Shares Down 6%May 14, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Trading Up 9.8%Cassava Sciences (NASDAQ:SAVA) Trading Up 9.8%May 10, 2024 | markets.businessinsider.comSAVA Stock Earnings: Cassava Sciences Beats EPS for Q1 2024May 10, 2024 | msn.comCassava swings to Q1 profit as more patients finish simufilam phase 3 trialsMay 10, 2024 | msn.comCassava Sciences (NASDAQ:SAVA): Cracking Alzheimer’s or Succumbing to Short Sellers?May 10, 2024 | globenewswire.comCassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of SimufilamMay 10, 2024 | seekingalpha.comAnnovis, Anavex, And Cassava Sciences: Trying To Box Oneself Out Of The Alzheimer's BoxMay 8, 2024 | msn.comCassava Sciences raises over $125M from warrant distributionMay 8, 2024 | globenewswire.comCassava Sciences Announces Over $125 Million Raised from Warrant DistributionMay 7, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Trading Down 6.3%Cassava Sciences (NASDAQ:SAVA) Stock Price Down 6.3%May 1, 2024 | msn.comCassava Sciences files for mixed shelf offeringMay 1, 2024 | msn.com27 Best Things to Do in San Francisco, CaliforniaMay 1, 2024 | msn.comCassava: The perilous past and promising future of a toxic but nourishing cropMay 1, 2024 | globenewswire.comTomorrow is Last Day to Trade SAVAW Warrants on NASDAQApril 30, 2024 | msn.comAATF launches mechanised cassava processing plant in OyoApril 30, 2024 | investorplace.comStock Market Crash Warning: Don't Get Caught Holding These 3 Biotech StocksApril 28, 2024 | msn.comExpensive sanitary pads: Agony of girls using clothes for menstruationApril 27, 2024 | msn.comCenterpiece program has crashed and burnedApril 27, 2024 | msn.comHow to grow cocoyamsApril 26, 2024 | msn.comExamining the impact of gene-based breeding on agriculture and medicineApril 26, 2024 | msn.comAdvancing cassava brown streak disease resistanceApril 25, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Trading Up 4.6%Cassava Sciences (NASDAQ:SAVA) Trading 4.6% HigherApril 20, 2024 | msn.comHow Western food imports are fuelling obesity in Pacific nationsApril 19, 2024 | finance.yahoo.comCassava Sciences, Inc. (SAVA)April 16, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Trading 6.2% Higher Cassava Sciences (NASDAQ:SAVA) Trading 6.2% HigherApril 15, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Sees Large Volume IncreaseCassava Sciences (NASDAQ:SAVA) Sees Large Volume IncreaseApril 15, 2024 | globenewswire.comRedemption Date Announced for WarrantsApril 12, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Trading Down 9%Cassava Sciences (NASDAQ:SAVA) Trading Down 9%April 11, 2024 | marketbeat.comInvestors Purchase Large Volume of Call Options on Cassava Sciences (NASDAQ:SAVA)Cassava Sciences, Inc. (NASDAQ:SAVA - Get Free Report) was the target of unusually large options trading on Thursday. Investors purchased 6,925 call options on the stock. This represents an increase of approximately 38% compared to the average daily volume of 5,002 call options.April 9, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Sees Strong Trading VolumeCassava Sciences (NASDAQ:SAVA) Sees Unusually-High Trading VolumeApril 8, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Trading Up 5.7%Cassava Sciences (NASDAQ:SAVA) Shares Up 5.7%April 5, 2024 | bizjournals.comAg nonprofit launched by Gates Foundation opens HQ in Cortex, grows to 30 employeesApril 4, 2024 | msn.comStrong quake rocks Taiwan, tsunami warnings issuedApril 3, 2024 | ft.comCan Africa one day help feed the world’s growing population?April 2, 2024 | stockhouse.com24 HOUR DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CassavaApril 2, 2024 | msn.comTracing science’s transformative impact on manifesto implementationApril 1, 2024 | stockhouse.comFINAL SAVA DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Cassava Sciences, Inc. Investors to Lead the Class Action Lawsuit!March 29, 2024 | prnewswire.comSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CassavaMarch 29, 2024 | finance.yahoo.comSAVA Apr 2024 17.000 putMarch 28, 2024 | msn.comCassava: How Nutrition Professionals Assess Its Health Benefits, Nutrition Facts, And MoreMarch 28, 2024 | marketbeat.comSG Americas Securities LLC Sells 184,073 Shares of Cassava Sciences, Inc. (NASDAQ:SAVA)SG Americas Securities LLC trimmed its position in Cassava Sciences, Inc. (NASDAQ:SAVA - Free Report) by 66.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 92,359 shares of theMarch 28, 2024 | markets.businessinsider.comSHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava SciencesMarch 27, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVAMarch 26, 2024 | au.investing.comCassava Sciences' Alzheimer's drug continues Phase 3 trialsMarch 25, 2024 | seekingalpha.comCassava Sciences: New Year, Same Game Of Smoke And MirrorsMarch 25, 2024 | markets.businessinsider.comDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CassavaMarch 25, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Shares Gap Up to $19.81Cassava Sciences (NASDAQ:SAVA) Shares Gap Up to $19.81 Get Cassava Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SAVA and its competitors with MarketBeat's FREE daily newsletter. Email Address The only AI company to buy (Ad)The AI boom is just getting started. And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. SAVA Media Mentions By Week SAVA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SAVA News Sentiment▼1.430.92▲Average Medical News Sentiment SAVA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SAVA Articles This Week▼25▲SAVA Articles Average Week Get Cassava Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SAVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Ironwood Pharmaceuticals News Today Enliven Therapeutics News Today Arcutis Biotherapeutics News Today Gyre Therapeutics News Today Liquidia News Today Verona Pharma News Today Innoviva News Today Collegium Pharmaceutical News Today AbCellera Biologics News Today Tyra Biosciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SAVA) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesThe only AI company to buyPorter & CompanyThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDigitizing the $11T commodities sector with one tiny stockResource Stock DigestWARNING about the death of the U.S. dollar…Colonial MetalsBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsIs Artificial Intelligence the Biggest Bubble in History?InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cassava Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
